Recombinant COVID-19 3C-like Proteinase | P1606

SARS-CoV-2 is a novel strain of coronavirus which causes the infectious disease COVID-19. 3C‐like protease is the main cysteine protease of the virus which hydrolyses viral polyproteins to produce functional proteins which is essential for coronavirus replication. It is an important therapeutic target for COVID-19.

P1606 | Recombinant COVID-19 3C-like Proteinase DataSheet

Biomolecule/Target :

Synonyms: SARS-CoV-2 3C-like Proteinase; SARS coronavirus main proteinase; M Proteinase, 3CL Proteinase, 3CL-Mpro, 3C-like main protease; 3C-like protease

Alternates names: SARS-CoV-2 3C-like Proteinase; SARS coronavirus main proteinase; M Proteinase, 3CL Proteinase, 3CL-Mpro, 3C-like main protease; 3C-like protease

Taglines: SARS‐CoV‐2 cysteine protease for the cleavage of viral precursor polyproteins

NCBI Gene ID #: QIZ13716.1

NCBI Gene Symbol:

Gene Source: Coronavirus

Accession #:

Recombinant: TRUE

Source: E.Coli

Purity by SDS-PAGE: ≥ 95% by SDS-PAGE

Assay:

Purity:

Assay #2:

Endotoxin Level:

Activity (Specifications/test method):

Biological activity:

Results:

Binding Capacity:

Unit Definition:

Molecular Weight: 33.79 kDa

Concentration: 1 ug/1 ul

Appearance: Liquid

Physical form description: Liquid

Reconstitution Instructions:

Amino acid sequence: aa 3264-3569

Handling: Centrifuge the vial prior to opening.

Usage: For Research Use Only! Not to be used in humans